کد مقاله کد نشریه سال انتشار مقاله انگلیسی ترجمه فارسی نسخه تمام متن
2649698 1139279 2014 8 صفحه PDF ندارد دانلود رایگان
عنوان انگلیسی مقاله
Surviving with lung cancer: Medication-taking and oral targeted therapy
ترجمه فارسی عنوان
زنده ماندن با سرطان ریه: درمان دارویی و درمان خوراکی
کلمات کلیدی
داروی مصرفی؛ گراندد تئوری؛ سرطان ریه سلول غیرکوچک؛ Erlotinib؛ گیرنده فاکتور رشد اپیدرمال
Medication-taking; Grounded theory; Non-small cell lung cancer; Erlotinib; Epidermal growth factor receptor
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی طب سالمندان و علم پیری شناسی
چکیده انگلیسی

Oral epidermal growth factor receptor inhibitors (EGFRIs) improve survival for non-small cell lung cancer (NSCLC) patients; however, medication-taking implications are unknown. We used grounded theory to explore the process of medication-taking for NSCLC patients receiving oral EGFRIs. Thirty-two interviews were conducted for 13 participants purposively selected for gender, race/ethnicity, age, time in therapy, dose reductions, and therapy discontinuation and theoretically sampled for age and health insurance carrier. The study produced a grounded theory, Surviving with Lung Cancer, in which participants framed EGFRI therapy within recognition of NSCLC as a life-limiting illness without cure. Medication-taking was a “window” into participants' process of surviving with metastatic cancer that included deciding and preparing to take EGFRIs and treating lung cancer as a chronic condition. Our results contribute to understanding how NSCLC patients view themselves in the context of a life-limiting illness and support development of a theoretically-based intervention to improve medication-taking with EGFRIs.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Geriatric Nursing - Volume 35, Issue 2, Supplement, March–April 2014, Pages S49–S56
نویسندگان
, , , , , ,